RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Timber Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Timber Pharmaceuticals Inc is TMBR and it is traded on the NYSEARCA (NYSE Arca).

Should I buy or sell Timber Pharmaceuticals Inc Stock?
Timber Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Timber Pharmaceuticals Inc Stock?
Timber Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Timber Pharmaceuticals Inc Stock.

What's the current price of Timber Pharmaceuticals Inc Stock?
As of the end of day on the 2024-02-27, the price of an Timber Pharmaceuticals Inc (TMBR) share was $0.343.

What is the 52-week high and low for Timber Pharmaceuticals Inc Stock?
The 52-week high for Timber Pharmaceuticals Inc Stock is $3.39 and the 52-week low is $0.320.

What is the market capitalization of Timber Pharmaceuticals Inc Stock?
As of the 2024-02-27, the market capitalization of Timber Pharmaceuticals Inc is 1.176M.

When is the next earnings date for Timber Pharmaceuticals Inc?
The upcoming earnings date for Timber Pharmaceuticals Inc is May 13, 2024.
Click to get the best stock tips daily for free!

About Timber Pharmaceuticals Inc

Timber Pharmaceuticals Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to severe subtypes of CI, a group of rare genetic keratinization disorders; and TMB-002, a proprietary top... TMBR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT